Active Pharmaceutical Ingredient (API)
Tazobactam
Beta-Lactamase Inhibitor
A powerful beta-lactamase inhibitor that is almost exclusively used in combination with a penicillin antibiotic, typically Piperacillin (forming Piperacillin/Tazobactam, often branded as Tazocin). Its role is to protect the penicillin from being destroyed by bacterial enzymes called beta-lactamases, thereby extending the antibiotic's spectrum of activity against resistant bacteria. The combination is a critical treatment for severe infections, including hospital-acquired pneumonia, and complicated abdominal or gynecological infections.
Technical Profile
- Reference Code
- TZB012
- CAS Number
- 89786-06-1
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Tazobactam as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Tazact 4.5g H1 | Cipla Ltd | Injection (500 mg) | ₹489.00 | View Details |
| Pipzo 4.5g H1 | Alkem Laboratories Ltd | Injection (500 mg) | ₹447.00 | View Details |
| Tazar 4.5g H1 | Lupin Ltd | Injection (500 mg) | ₹465.00 | View Details |
| Zosyn 4.5g H1 | Pfizer Ltd | Injection (500 mg) | ₹546.00 | View Details |
| Nataxone TZ Inj 1.125gm H1 | Ancalima Lifesciences Ltd | Injection (125 mg) | ₹176.20 | View Details |
| Natapime TZ Inj. 281.25 mg H1 | Ancalima Lifesciences Ltd | Injection (31.25 mg) | ₹105.00 | View Details |
| P-Zodime Inj 1.125 gm H1 | Ancalima Lifesciences Ltd | Injection (125 mg) | ₹318.70 | View Details |
| P-Zobact Inj 4.5 gm H1 | Ancalima Lifesciences Ltd | Injection (500 mg) | ₹419.00 | View Details |